Chimeric Antigen Receptor T-Cell Therapy and Bispecific Antibody Use in Earlier Lines of Treatment of Large B-Cell Lymphoma, Follicular Lymphoma, and Mantle Cell Lymphoma Treatment of multiple myeloma ...

Cell-based therapies have become integral to the routine clinical management of hematologic malignancies. Tumor-infiltrating lymphocyte (TIL) therapy has demonstrated efficacy in immunogenic solid ...

Michael Morse, MD, FACP, MHS, professor of medicine at Duke University School of Medicine and medical oncologist at Duke Cancer Center, spoke to the evolution of hepatocellular carcinoma (HCC) ...

A new report from the National Academies of Sciences, Engineering, and Medicine calls for increased collaboration between behavioral economists and policymakers and examines the future research ...

The session will bring together key emergency management leaders to discuss the current state and future direction of the Federal Emergency Management Agency (FEMA), as well as broader challenges ...

October in Berlin, Germany, where internationally renowned oncology experts will present cutting-edge data and engage in thought-provoking discussions covering the current advances and future ...